J. Lautenschläger

Present state of medication therapy in fibromyalgia syndrome

J. Lautenschläger, 2000, Scandinavian journal of rheumatology. Supplement.

[Generalized tendomyopathy. I: Clinical aspects, follow-up and differential diagnosis].

W. Müller, J. Lautenschläger, 1990, Zeitschrift fur Rheumatologie.

[Measuring pressure pain of tendons and muscles in healthy probands and patients with generalized tendomyopathy (fibromyalgia syndrome)].

W. Müller, W. Brückle, J. Lautenschläger, 1988, Zeitschrift fur Rheumatologie.

[Electron microscopy studies on the distribution of cholinesterases in rat megakaryocytes].

P. Meusers, J. Lautenschläger, R. Borst, 1971, Histochemie. Histochemistry. Histochimie.

Letter: Cerebral convulsions and cardiac arrest during local anesthesia in patient on antiarrhythmic treatment.

G. Breithardt, H. Schulte, L. Seipel, 1975, Chest.

Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study.

H. Probst, A. Yavari, J. Thiery, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire].

T. Kohlmann, H. Raspe, H. Zeidler, 1997, Zeitschrift fur Rheumatologie.

[Acupuncture in treatment of inflammatory rheumatic diseases].

J. Lautenschläger, 1997, Zeitschrift für Rheumatologie (Print).

[Paraquat intoxication and isolated aplastic anaemia (author's transl)].

B. Grabensee, J. Lautenschläger, W. Pöttgen, 1974, Deutsche medizinische Wochenschrift.

Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.

D. Pongratz, L. Färber, H. Peter, 2000, Scandinavian journal of rheumatology. Supplement.

Dodecin as carrier protein for immunizations and bioengineering applications

R. Vabulas, M. Grininger, H. Besir, 2020, Scientific Reports.

Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.

D. Pongratz, L. Färber, H. Peter, 2001, International journal of clinical pharmacology research.

[Localized pressure pain in the diagnosis of generalized tendomyopathy (fibromyalgia)].

W. Müller, W. Brückle, J. Lautenschläger, 1989, Zeitschrift fur Rheumatologie.